Related Experiment Videos

A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their

S Tagami1, Y Eguchi, M Kinoshita

  • 1Department of Medical Genetics, Biomedical Research Center, Osaka University Graduate School of Medicine, Suita, Japan.

Oncogene
|December 29, 2000
PubMed

Insights

Reticulon (RTN) proteins, NSP-C and RTN-XS, bind to anti-apoptotic proteins Bcl-XL and Bcl-2. This interaction modulates their activity and localization, impacting apoptosis regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Bcl-2 and Bcl-XL are key regulators of apoptosis, primarily functioning at the mitochondria.
  • Apoptosis, or programmed cell death, is a crucial biological process.
  • Mitochondrial and endoplasmic reticulum (ER) pathways are central to apoptosis.

Purpose of the Study:

  • To investigate the interaction between reticulon (RTN) proteins and Bcl-2 family members.
  • To determine if RTN proteins modulate the anti-apoptotic function of Bcl-XL and Bcl-2.
  • To identify the cellular localization of these interactions.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Immunofluorescence microscopy to determine protein localization.
  • Functional assays to assess anti-apoptotic activity.

Main Results:

  • NSP-C (RTN1-C) and RTN-XS, both RTN family proteins, were identified as Bcl-XL binding partners.
  • RTN-XS also interacted with Bcl-2, while NSP-C did not.
  • Both RTN proteins altered the localization of Bcl-XL and Bcl-2 to the endoplasmic reticulum (ER) and reduced their anti-apoptotic activity.

Conclusions:

  • RTN family proteins can bind to and modulate the activity of Bcl-XL and Bcl-2.
  • These interactions influence the subcellular localization of Bcl-XL and Bcl-2, shifting them to the ER.
  • RTN proteins represent novel regulators of apoptosis through their interaction with Bcl-2 family members.

Related Concept Videos